Profits fall for pharmaceutical company CSL to $US1.62 billion

  • 📰 SkyNewsAust
  • ⏱ Reading Time:
  • 6 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 6%
  • Publisher: 78%

المملكة العربية السعودية أخبار أخبار

المملكة العربية السعودية أحدث الأخبار,المملكة العربية السعودية عناوين

Blood products and pharmaceuticals company CSL saw their profit for the first half year fall eight per cent to $US1.62 billion as the result of one-off costs associated with its $16 billion takeover of Swiss company Vifor Pharma.

It’s also the final result from Chief Executive Paul Perreault – who has headed the

company for almost 10 years, where CSL shares have increased more than three-and-a-half times.

 

شكرًا لك على تعليقك. سيتم نشر تعليقك بعد مراجعته.

How the hell can this mob lose money 💵 with what they charge for a blood transfusion 😱

Sir in my family there are 7 members mother, father old age with their medicine it is impossible to run the family. I owe a lot of money and now I am bankrupt. Please give me a work visa so that I and my family can live.

لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:

 /  🏆 7. in SA

المملكة العربية السعودية أحدث الأخبار, المملكة العربية السعودية عناوين